(Q36605358)

15 August 2017

1 reference

title

An approach to the evaluation and treatment of Cushing's disease (English)

1 reference

15 August 2017

Rebecca L Brown

1

1 reference

15 August 2017

Roy E Weiss

series ordinal

2

1 reference

15 August 2017

publication date

1 September 2006

1 reference

Expert Review of Anticancer Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

6 Suppl 9

1 reference

15 August 2017

page(s)

S37-46

1 reference

Clinical and biochemical evaluation of Cushing's syndrome

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Morbidity and mortality in Cushing's disease: an epidemiological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Diagnosis and complications of Cushing's syndrome: a consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Diagnosis and differential diagnosis of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Screening and diagnosis of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Nighttime salivary cortisol measurement as a simple, noninvasive, outpatient screening test for Cushing's syndrome in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

The pituitary "incidentaloma".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Pituitary surgery and postoperative management in Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Serum cortisol response to transsphenoidal surgery for Cushing disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Intra- and postoperative plasma ACTH concentrations in patients with Cushing's disease cured by transsphenoidal pituitary surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

What can predict postoperative "endocrinological cure" in Cushing's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Repeat transsphenoidal surgery for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Radiation therapy for Cushing's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

21 January 2018

Pituitary radiotherapy

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Medical therapy of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Rosiglitazone for prevention or adjuvant treatment of Nelson's syndrome after bilateral adrenalectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome--recommendations for a protocol for biochemistry laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

The effects of anti-convulsant drugs on adrenal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9S.S37

10.1586/14737140.6.9S.S37

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference